Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) SLC39A6 Antibodies:
anti-Human SLC39A6 Antibodies:
anti-Rat (Rattus) SLC39A6 Antibodies:
Go to our pre-filtered search.
Cow (Bovine) Polyclonal SLC39A6 Primary Antibody for IHC, WB - ABIN2781630
Trokovic, Pöllänen, Porola, Stegaev, Hetzel, Tivesten, Engdahl, Carlsten, Forsblad-dElia, Fagman, Lagerquist, Konttinen: Exosomal secretion of death bullets: a new way of apoptotic escape? in American journal of physiology. Endocrinology and metabolism 2012
results establish a molecular link between STAT3 (show STAT3 Antibodies), LIV1 and Snail (show SNAI1 Antibodies) in epithelial-mesenchymal transition in gastrula organizer; LIV1 is essential for the nuclear localization of zinc-finger protein (show FEZF2 Antibodies) Snail (show SNAI1 Antibodies)
PrP and ZIP6 inherited the ability to interact with NCAM1 (show NCAM1 Antibodies) from their common ZIP ancestors but have since diverged to control distinct posttranslational modifications of NCAM1 (show NCAM1 Antibodies).
Zip 6 dysregulation was involved in enhanced inflammation during aging.
mice fed low-Zn diet had reduced number of terminal deoxynucleotidyl transferase (show DNTT Antibodies) dUTP (show DUT Antibodies) nick end labeling-positive cells compromised seminiferous tubule structure, and reduced Zip10 (show SLC39A10 Antibodies) and Zip6 abundance (>50%; P < 0.5) compared with control diet
ZIP6 deficiency disturbs intracellular Zn2+ homeostasis, leading to increased cell survival in hypoxia and reduced E-cadherin (show CDH1 Antibodies) expression, indicating that decreased ZIP6 expression is strongly associated with resistance to hypoxia.
SLC39A6 promotes aggressiveness of esophageal carcinoma cells by increasing intracellular levels of zinc, activating phosphatidylinositol 3-kinase signaling, and up-regulating genes that regulate metastasis.
Upregulation of SLC39A6 is associated with hepatocellular carcinoma.
SLC39A6 may have a tumor promoting role in esophageal carcinoma
Knock-down of ZIP6 but not ZIP7 (show SLC39A7 Antibodies) in MIN6 beta cells impaired the protective effects of GLP-1 (show GCG Antibodies) on fatty acid-induced cell apoptosis, possibly via reduced activation of the p-ERK (show EPHB2 Antibodies) pathway
drug resistance of ovarian cancer cells to trichostatin A may be related to expression of the LIV1 gene
Zinc and its transporters, ZIP6 and ZIP10 (show SLC39A10 Antibodies), are required for the breast cancer cells motility stimulated with high glucose level, such as in diabetes.
a causative role for ZIP6 in cell motility and migration
Down-regulated LIV-1 cells showed significant inhibition of proliferation in vitro and reduction of tumor growth in vivo. Furthermore, E-cadherin expression increased in LIV-1 siRNA expressing Hep-G2.
SLC39A6 has an important role in the prognosis of esophageal squamous-cell carcinoma and may be a potential therapeutic target.
Zinc is an essential cofactor for hundreds of enzymes. It is involved in protein, nucleic acid, carbohydrate, and lipid metabolism, as well as in the control of gene transcription, growth, development, and differentiation. SLC39A6 belongs to a subfamily of proteins that show structural characteristics of zinc transporters (Taylor and Nicholson, 2003
zinc transporter ZIP6
, solute carrier family 39 (zinc transporter), member 6
, zrt- and Irt-like protein 6
, solute carrier family 39 member 6
, solute carrier family 39, member 6
, endoplasmic reticulum membrane protein
, endoplasmic reticulum membrane-linked protein
, LIV-1 protein, estrogen regulated
, estrogen-regulated protein LIV-1
, solute carrier family 39 (metal ion transporter), member 6
, estrogen-regulated LIV-1 protein